Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
Recruiting now
Conditions studied: Dermatomyositis
In brief
Dermatomyositis is a rare chronic autoimmune and inflammatory disease that affects the skin and striated muscles. Its prognosis is linked to visceral involvement (lungs, heart, and oropharyngeal region) and to the possible presence of associated cancer. The implementation of the research will allow identification of incident cases of dermatomyositis in Guadeloupe and the characterization of the disease in the overseas population, in the absence of data in the literature.
Key facts
- Study ID
- NCT07265999
- Run by
- Centre Hospitalier Universitaire de la Guadeloupe
- People needed
- 10
- Starts
- 2021-07-16
- Expected to finish
- 2029-07-16
- Last updated by the study team
- 2025-12-05
Who can join
Age: 16 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient with a diagnosis of dermatomyositis according to the 2003 ENMC criteria
- Patient with parents or grandparents originating from the Caribbean arc
- Patient aged 16 years or older
- Patient residing in Guadeloupe
- Patient (or legal representative) who has received information about the study and has signed the informed consent form
- Patient affiliated with a social security scheme
You may not qualify if…
- Patient who started treatment with intravenous immunoglobulins, corticosteroids, or immunosuppressants within the month prior to the diagnosis of dermatomyositis
- Patient under legal protection (guardianship or trusteeship) or deprived of liberty
Where it is running
- CHU de la Guadeloupe — Pointe-à-Pitre, Guadeloupe (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.